liver cancer
Eureka, City of Hope Begin Phase I/II Trial of T-Cell Therapy in GPC3-Positive Liver Cancer
The partners will enroll 12 patients with GPC3-positive tumors who have failed or not tolerated at least two prior systemic agents.
SCG Cell Therapy to Begin Trials of T-Cell Receptor Therapy for Liver Cancer Patients in Singapore
The firm received IND clearance from regulators in Singapore and China to begin evaluating its therapy SCG101 for HBV-associated hepatocellular carcinoma patients.
Merck Nabs European Approvals for Keytruda in Cervical Cancer, Biomarker-Defined Solid Tumors
European regulators approved the agent for PD-L1-positive cervical cancer and for five tumor types defined by high microsatellite instability or DNA mismatch repair deficiency.
Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer
The collaborators will focus on the commercialization of HepatoPredict, a prognostic gene expression test to identify patients for liver transplantation.
GC Cell Licenses Liver Cancer Cell Therapy to Rivaara Immune in India
South Korea-based GC Cell and India-based Rivaara have inked a licensing agreement to commercialize the autologous treatment in India, Sri Lanka, and Bangladesh.